Patent details

Basic Information

Publication number:

EP3402817

PCT Application Number:

US2017012795

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177034915

PCT Publication Number:

WO2017123517

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-N3-BETA-GLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF

French Title of Invention:

ANTICORPS ANTI-PEPTIDES BÊTA-AMYLOÏDES N3-BÊTA-GLU ET UTILISATIONS ASSOCIÉES

German Title of Invention:

AMYLOID-BETA-PEPTIDANTIKÖRPER GEGEN N3-BETA-GLU UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

10/01/2017

Grant date:

18/10/2023

EP Publication Date:

21/11/2018

PCT Publication Date:

20/07/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/10/2023

EP B1 Publication Date:

18/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/01/2024

Expiration date:

10/01/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/10/2023

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

1

Name:

TANG, Ying

Address:

United States (US)

2

Name:

LU, Jirong

Address:

United States (US)

3

Name:

DEMATTOS, Ronald Bradley

Address:

United States (US)

Priority

Priority Number:

201662279268 P

Priority Date:

15/01/2016

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/18; A61K 39/00;

Publication

European Patent Bulletin

Issue number:

202342

Publication date:

18/10/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages